Arsanis, Inc. Contracts & Agreements

169 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Agreement, dated August 8, 2018, by and between the Registrant and the Bill & Melinda Gates Foundation
Arsanis, Inc.
Biotechnology
GA
2018
Amendment No. 3 to Master Services Agreement, dated August 3, 2023, by and between X4 Pharmaceuticals Inc., and Catalent
Services Agreements
Arsanis, Inc.
2024
First Amendment to Second Amended and Restated Loan and Security Agreement, dated as of August 2, 2023, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules...
Loan Agreements
Arsanis, Inc.
2023
X4 Pharmaceuticals, Inc. Amended and Restated 2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2023
X4 Pharmaceuticals, Inc. Amended and Restated 2017 Employment Stock Purchase Plan
Stock Agreements
Arsanis, Inc.
2023
Form of May 2023 Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
2023
Securities Purchase Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
2023
Registration Rights Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
2023
X4 Pharmaceuticals, Inc. Amended and Restated 2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2022
Underwriting Agreement, dated December 7, 2022, by and among the Company, Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, and Cantor Fitzgerald & Co
Underwriting Agreements
Arsanis, Inc.
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
2022
Form of Class C Warrant
Warrant Agreements
Arsanis, Inc.
2022
Form of Stock Appreciation Right Agreement under the X4 Pharmaceuticals, Inc. Amended and Restated 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
2022
Form of Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Registration Rights Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
2022
Amendment No. 4 to Amended and Restated Loan and Security Agreement, dated as of June 30, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries...
Loan Agreements
Arsanis, Inc.
2022
Second Amended and Restated Executive Employment Agreement, dated as of March 7, 2022 by and between the Company and Adam S. Mostafa
Employment Agreements
Arsanis, Inc.
2022
Amended and Restated Executive Employment Agreement, dated as of March 7, 2022 by and between the Company and Derek Meisner
Employment Agreements
Arsanis, Inc.
Biotechnology
MA
2022
Amended and Restated Executive Employment Agreement, dated as of March 7, 2022 by and between the Company and Art Taveres
Employment Agreements
Arsanis, Inc.
2022
Amended and Restated Executive Employment Agreement, dated as of March 7, 2022 by and between the Company and Diego Cadavid
Employment Agreements
Arsanis, Inc.
2022
Amended and Restated Executive Employment Agreement, dated as of March 7, 2022 by and between the Company and Mary DiBiase
Employment Agreements
Arsanis, Inc.
Biotechnology
MA
2022
Form of Pre-Funded
Arsanis, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
2022
Registration Rights Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
2022
Amendment No. 3 to Amended and Restated Loan and Security Agreement, dated as of February 9, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries...
Loan Agreements
Arsanis, Inc.
Biotechnology
2022
Purchase Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
Purchase Agreements
Arsanis, Inc.
2022
Registration Rights Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Arsanis, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Securities Purchase Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Registration Rights Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Third Amendment to Option Agreement, dated July 15, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
2021
Second Amendment to Option Agreement, dated June 7, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
Biotechnology
DE
2021
First Amendment to Option Agreement dated May 3, 2021, by and between X4 Pharmaceuticals Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
2021
Description of Registered Securities
Arsanis, Inc.
Biotechnology
2021
Executive Employment Agreement, dated as of October 21, 2020, by and between the Company and Art Taveres
Employment Agreements
Arsanis, Inc.
2021
Executive Employment Agreement, dated as of November 23, 2020, by and between the Company and Diego Cadavid
Employment Agreements
Arsanis, Inc.
Biotechnology
MA
2021
License Agreement, dated as of November 13, 2020, by and between X4 Pharmaceuticals Inc. and the Dana Farber Cancer Institute
License Agreements
Arsanis, Inc.
Biotechnology
MA
2021
Amendment No. 2 to Master Services Agreement, dated February
Services Agreements
Arsanis, Inc.
Biotechnology
2021
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
2021
Securities Purchase Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Registration Rights Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Option Agreement, dated March 18, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Arsanis, Inc.
2021
Amendment No. 2 to Amended and Restated Loan and Security Agreement, dated as of December 21, 2020, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries...
Loan Agreements
Arsanis, Inc.
Biotechnology
2020
Consulting agreement, dated September 17 2020, by and between X4 Pharmaceuticals Inc. and Gary Bridger
Consulting Agreements
Arsanis, Inc.
Biotechnology
MA
2020
Lease Termination Agreement, dated July 17, 2020, by and between 955 Massachusetts Avenue MA, LLC and X4 Pharmaceuticals, Inc
Lease Agreements
Arsanis, Inc.
2020
Registration Rights Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC
Registration Rights Agreements
Arsanis, Inc.
2020
Common Stock Purchase Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC
Stock Agreements
Arsanis, Inc.
2020
Amendment to Amended and Restated Executive Employment Agreement, dated as of March 13, 2019, dated February 13, 2020 by and between the Company and Paula Ragan, Ph.D
Employment Agreements
Arsanis, Inc.
Biotechnology
2020
Resignation Agreement and Release by and between X4 Pharmaceuticals, Inc. and E. Lynne Kelley, M.D., dated March 18, 2020
Release Agreements
Arsanis, Inc.
Biotechnology
MA
2020
Amendment No. 1 to Loan and Security Agreement, dated March 13, 2020, by and between X4 Pharmaceuticals, Inc. and Hercules Capital, Inc
Loan Agreements
Arsanis, Inc.
2020
Description of Registered Securities
Arsanis, Inc.
2020
Executive Employment Agreement, dated as of April 16, 2019, by and between the Company and E. Lynne Kelley
Employment Agreements
Arsanis, Inc.
Biotechnology
MA
2020
Amendment to Amended and Restated Executive Employment Agreement, dated as of March 13, 2019, dated February 13, 2020 by and between the Company and Paula Ragan, Ph.D
Employment Agreements
Arsanis, Inc.
Biotechnology
2020
Amendment to Amended and Restated Executive Employment Agreement, dated as of February 24, 2020 by and between the Company and Adam S. Mostafa
Employment Agreements
Arsanis, Inc.
2020
Amendment to Executive Employment Agreement, dated as of March 5, 2020, by and between the Company and E. Lynne Kelley
Employment Agreements
Arsanis, Inc.
2020
Executive Employment Agreement, dated as of September 25, 2019, by and between the Company and Derek Meisner
Employment Agreements
Arsanis, Inc.
Biotechnology
MA
2020
Amendment to Executive Employment Agreement, dated as of February 24, 2020, by and between the Company and Derek Meisner
Employment Agreements
Arsanis, Inc.
2020
Master Services Agreement, dated September 10, 2015, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc. (formerly known as Metrics, Inc.)
Services Agreements
Arsanis, Inc.
2020
Amendment No. 1 to Master Services Agreement, dated August 25, 2017, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc. (formerly known as Metrics, Inc.)
Services Agreements
Arsanis, Inc.
2020
Amendment No. 2 to Master Services Agreement, dated February 28, 2020, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc
Services Agreements
Arsanis, Inc.
2020
Master Services Agreement, dated February 19, 2016, by and between X4 Pharmaceuticals Inc. and Aptuit (Oxford) Limited
Services Agreements
Arsanis, Inc.
2020
Amendment No. 1 to Master Services Agreement, dated February 19, 2016, by and between X4 Pharmaceuticals Inc. and Aptuit (Oxford) Limited
Services Agreements
Arsanis, Inc.
Biotechnology
2020
Lease, dated as of November 11, 2019, by and between X4 Pharmaceuticals Inc. and Beacon North Village, LLC
Lease Agreements
Arsanis, Inc.
Biotechnology
MA
2020
Underwriting Agreement, dated November 26, 2019, by and among the Company, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated
Underwriting Agreements
Arsanis, Inc.
2019
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
2019
Form of Class B Warrant
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Amended and Restated Loan and Security Agreement, dated as of June 27, 2019, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules Capital, Inc. and Hercules...
Loan Agreements
Arsanis, Inc.
2019
X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
DE
2019
Form of Stock Option Agreement under the 2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
2019
Form of Restricted Stock Agreement under the 2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
DE
2019
Form of Restricted Stock Unit Agreement under the 2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2019
Form of Restricted Stock Unit Agreement under the Companys 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
DE
2019
Form of Restricted Stock Unit Agreement under the Companys 2015 Employee, Director and Consultant Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
DE
2019
Amended and Restated Warrant Agreement, dated as of March 29, 2019, by and between the Company and Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Warrant Agreement, dated as of March 18, 2019, by and between the Company and Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Form of Restricted Stock Agreement under the 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2019
Form of Nonstatutory Stock Option Agreement (Director Grants) under the 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2019
Form of Nonstatutory Stock Option Agreement under the 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
2019
Form of Incentive Stock Option Agreement under the 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2019
License Agreement, dated as of July 10, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, LLC) and Genzyme Corp., a Sanofi company
License Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Amendment No. 1 to License Agreement, dated as of October 23, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Genzyme Corporation, a Sanofi...
License Agreements
Arsanis, Inc.
Biotechnology
2019
License Agreement, dated as of December 13, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Georgetown University
License Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Exclusive License Agreement, dated as of December 23, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Beth Israel Deaconess Medical Center
License Agreements
Arsanis, Inc.
Biotechnology
MA
2019
Underwriting Agreement, dated April 12, 2019, by and among the Company, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated
Underwriting Agreements
Arsanis, Inc.
2019
Form of Pre-Funded Warrant
Warrant Agreements
Arsanis, Inc.
2019
Form of Class A Warrant
Warrant Agreements
Arsanis, Inc.
2019
Settlement Agreement, dated as of March 8, 2019, by and among X4 Pharmaceuticals, Inc. (formerly Arsanis, Inc.), Artemis AC Corp., X4 Therapeutics, Inc. (formerly X4...
Settlement Agreements
Arsanis, Inc.
2019
Form of Stock Option Agreement under the 2015 Employee, Director and Consultant Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Arsanis, Inc.
2019
Form of Common Stock Certificate
Stock Agreements
Arsanis, Inc.
Biotechnology
2019
Form of Warrant to Purchase Series A Preferred Stock of X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) issued to Silicon Valley Bank and Life Science Loans, LLC
Warrant Agreements
Arsanis, Inc.
2019
Form of Warrant to Purchase Series A Preferred Stock of X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) issued to Maxim Partners LLC
Warrant Agreements
Arsanis, Inc.
2019
Form of Warrant to Purchase Series B Preferred Stock of X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.)
Warrant Agreements
Arsanis, Inc.
2019
Form of Warrant to Purchase Series B Preferred Stock of X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) issued to Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
2019
Warrant Modification Agreement, dated as of December 11, 2018, by and among X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
Biotechnology
2019
2015 Employee, Director and Consultant Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Arsanis, Inc.
2019
Form of Stock Option Agreement under the 2015 Employee, Director and Consultant Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Arsanis, Inc.
2019
Director Compensation Policy
Compensation Agreements
Arsanis, Inc.
Biotechnology
2019
Amended and Restated Executive Employment Agreement, dated as of March 13, 2019, by and between the Company and Paula Ragan, Ph.D
Employment Agreements
Arsanis, Inc.
Biotechnology
MA
2019
Amended and Restated Executive Employment Agreement, dated as of March 13, 2019, by and between the Company and Adam S. Mostafa
Employment Agreements
Arsanis, Inc.
2019
License Agreement, dated as of July 10, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, LLC) and Genzyme Corp., a Sanofi company
License Agreements
Arsanis, Inc.
2019
Amendment No. 1 to License Agreement, dated as of October 23, 2014, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Genzyme Corporation, a Sanofi...
License Agreements
Arsanis, Inc.
2019
License Agreement, dated as of December 13, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Georgetown University
License Agreements
Arsanis, Inc.
2019
Exclusive License Agreement, dated as of December 23, 2016, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Beth Israel Deaconess Medical Center
License Agreements
Arsanis, Inc.
Biotechnology
MA
2019
Loan and Security Agreement, dated as of October 19, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc
Loan Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Amendment No. 1 to Loan and Security Agreement, dated as of December 11, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc
Loan Agreements
Arsanis, Inc.
Biotechnology
2019
Lease, dated as of January 20, 2017, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Brickman 955 Massachusetts LLC
Lease Agreements
Arsanis, Inc.
2019
Second Amendment to Agreement and Plan of Merger, dated March 8, 2019, by and among Arsanis, Inc., Artemis AC Corp. and X4 Pharmaceuticals, Inc
Merger Agreements
Arsanis, Inc.
Biotechnology
DE
2019
Lease Termination Agreement, dated February 26, 2019, by and between Arsanis Biosciences GmbH and Wstenrot Marxbox GmbH & Co. OG (as successor-in-interest to Marxbox Bauprojekt...
Lease Agreements
Arsanis, Inc.
Biotechnology
2019
First Amendment to Agreement and Plan of Merger, dated December 20, 2018, by and among Arsanis, Inc., Artemis AC Corp. and X4 Pharmaceuticals, Inc
Merger Agreements
Arsanis, Inc.
Biotechnology
DE
2018
Agreement and Plan of Merger, dated November 26, 2018, by and among Arsanis, Inc., Artemis AC Corp. and X4 Pharmaceuticals, Inc
Merger Agreements
Arsanis, Inc.
2018
Form of Support Agreement, dated November 26, 2018, by and among Arsanis, Inc., X4 Pharmaceuticals, Inc. and certain stockholders of Arsanis, Inc
Arsanis, Inc.
2018
Form of Support Agreement, dated November 26, 2018, by and among Arsanis, Inc., X4 Pharmaceuticals, Inc. and certain officers, directors and stockholders of X4 Pharmaceuticals, Inc
Arsanis, Inc.
Biotechnology
DE
2018
2018 Amended and Restated Employment Agreement, dated November 26, 2018, by and between Arsanis, Inc. and Michael Gray
Employment Agreements
Arsanis, Inc.
2018
Letter Agreement, dated November 26, 2018, by and between Arsanis, Inc. and Ren Russo
Arsanis, Inc.
2018
Retention Bonus Agreement, dated November 26, 2018, by and between Arsanis, Inc. and Christopher Stevens
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
MA
2018
Form of Restricted Stock Agreement under the 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
DE
2018
First Amendment to Lease, dated August 10, 2018, by and between the Registrant and BP Bay Colony LLC
Lease Agreements
Arsanis, Inc.
2018
Grant Agreement, dated August 8, 2018, by and between the Registrant and the Bill & Melinda Gates Foundation
Arsanis, Inc.
Biotechnology
2018
Forbearance Agreement, dated August 8, 2018, by and between the Registrant and Silicon Valley Bank
Forbearance Agreements
Arsanis, Inc.
2018
Indenture of Lease, dated June 6 2018, by and between the Company and BP Bay Colony LLC
Indenture Agreements
Arsanis, Inc.
Biotechnology
DE
2018
Share Purchase Agreement, dated as of November 15, 2017, by and between the Company and New Enterprise Associates 16, L.P
Share Agreements
Arsanis, Inc.
2018
Arsanis, Inc. [] Shares Common Stock ($0.001 parvalue) Underwriting Agreement
Underwriting Agreements
Arsanis, Inc.
2017
ARSANIS, INC. SECONDAMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT Dated as of April 12, 2016 Amended as of November 3, 2017
Investor Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2017
INDEMNIFICATION AGREEMENT
Indemnification Agreements
Arsanis, Inc.
Biotechnology
DE
2017
ARSANIS, INC. SECONDAMENDED AND RESTATED STOCKHOLDERS AGREEMENT Dated as of April 12, 2016 Amended as of November 3, 2017 TABLE OF CONTENTS
Arsanis, Inc.
2017
Specimen Stock Certificate evidencing the shares of common stock
Stock Agreements
Arsanis, Inc.
2017
Second Amended and Restated Investors Rights Agreement, as amended
Investor Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2017
2010 Special Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Arsanis, Inc.
2017
Form of Non-Statutory Stock Option Agreement under the 2010 Special Stock Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
Biotechnology
2017
2011 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Arsanis, Inc.
2017
Form of Incentive Stock Option Agreement under the 2011 Stock Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2017
Form of Non-Statutory Stock Option Agreement under the 2011 Stock Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2017
2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2017
Form of Incentive Stock Option Agreement under the 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2017
Form of Nonstatutory Stock Option Agreement under the 2017 Equity Incentive Plan
Bonus & Incentive Agreements
Arsanis, Inc.
2017
2017 Employee Stock Purchase Plan
Stock Agreements
Arsanis, Inc.
Biotechnology
DE
2017
Offer letter, dated July 12, 2015, by and between the Registrant and Ren Russo
Arsanis, Inc.
Biotechnology
2017
Offer letter, dated January 15, 2016, by and between the Registrant and Michael Gray
Arsanis, Inc.
Biotechnology
2017
Offer letter, dated April 28, 2016, by and between the Registrant and Chris Stevens
Arsanis, Inc.
2017
Form of Indemnification Agreement between Registrant and each of William Clark, Carl Gordon, David McGirr, Terrance McGuire, Claudio Nessi, Michael Ross and Amy Schulman
Indemnification Agreements
Arsanis, Inc.
Biotechnology
DE
2017
Form of Indemnification Agreement between Registrant and each of Eszter Nagy, Tillman U. Gerngross and Rene Russo
Indemnification Agreements
Arsanis, Inc.
2017
Lease, dated October 30, 2015, by and between the Registrant and Waltham Winter Street 890 LP and the Registrant
Lease Agreements
Arsanis, Inc.
2017
Lease Agreement, dated November 26, 2010, by and between Arsanis Biosciences GmbH and Wstenrot Marxbox GmbH & Co. OG (as successor-in-interest to Marxbox Bauprojekt GmbH & Co....
Lease Agreements
Arsanis, Inc.
Biotechnology
2017
Collaboration Agreement, dated as of May 1, 2011, by and between the Registrant and Adimab, LLC, as amended
Collaboration Agreements
Arsanis, Inc.
Biotechnology
NY
2017
Option and License Agreement, dated as of February 27, 2017, by and between the Registrant and Adimab, LLC
License Agreements
Arsanis, Inc.
2017
Grant Agreement, dated February 20, 2017, by and between the Registrant and Bill & Melinda Gates Foundation, as amended
Arsanis, Inc.
2017
Letter agreement, dated as of April 24, 2017, by and between the Registrant and Bill & Melinda Gates Foundation
Arsanis, Inc.
2017
Loan and Security Agreement, dated as of December 7, 2012, by and between the Registrant and Silicon Valley Bank, as amended
Loan Agreements
Arsanis, Inc.
2017
Warrant to purchase shares of Series A-2 Convertible Preferred Stock issued by the Registrant to Silicon Valley Bank
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2017
Warrant to purchase shares of Series B Convertible Preferred Stock issued by the Registrant to Silicon Valley Bank
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2017
Funding contract, dated September 20, 2011, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
2017
Funding contract, dated July 2, 2012, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated December 5, 2012, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated March 29, 2013, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated August 6, 2013, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated April 3, 2014, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
2017
Funding contract, dated June 9, 2014, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
2017
Funding contract, dated July 20, 2015, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
2017
Funding contract, dated July 20, 2015, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
Biotechnology
2017
Funding contract, dated July 14, 2016, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
2017
Funding contract, dated March 23, 2017, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation)
Funding Agreements
Arsanis, Inc.
2017
Form of Indemnification Agreement to be entered into between the Registrant and each of its directors and executive officers
Indemnification Agreements
Arsanis, Inc.
Biotechnology
DE
2017
Second Amended and Restated Stockholders Agreement, dated as of April 12, 2016, among the Registrant and the other parties thereto, as amended
Arsanis, Inc.
Biotechnology
DE
2017
Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Ren Russo (to be effective upon the closing of this offering)
Arsanis, Inc.
Biotechnology
2017
Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Michael Gray (to be effective upon the closing of this offering)
Arsanis, Inc.
Biotechnology
2017
Amended and Restated Offer Letter, dated October 10, 2017, by and between the Registrant and Chris Stevens (to be effective upon the closing of this offering)
Arsanis, Inc.
2017
Amendment No. 1 to the Option and License Agreement, dated as of February 27, 2017, by and between the Registrant and Adimab, LLC, dated as of October 13, 2017
License Agreements
Arsanis, Inc.
2017